Current Drug Delivery (CDD)

Current Drug Delivery is a peer‑reviewed, international journal dedicated to publishing high-quality research and reviews on the design, development, and evaluation of drug delivery systems. The journal serves as a platform for pharmaceutical scientists, clinicians, and researchers to share innovative strategies and technologies for targeted, controlled, and efficient drug administration. Its scope includes conventional and advanced delivery systems, nanocarriers, liposomes, nanoparticles, micelles, hydrogels, and other novel platforms for small molecules, peptides, proteins, nucleotides, and biologics. Current Drug Delivery emphasizes mechanistic studies, transport phenomena, pharmacokinetics, pharmacodynamics, and overcoming biological barriers to optimize therapeutic efficacy. The journal also covers clinical translation of delivery technologies, regulatory considerations, and safety assessments, bridging basic research with practical applications. Published by Bentham Science Publishers, it maintains rigorous peer-review standards to ensure scientific accuracy, relevance, and quality. Indexed in major databases including PubMed, Scopus, Web of Science, and Dimensions, the journal ensures wide accessibility and visibility for authors and readers. With a monthly publication schedule, Current Drug Delivery facilitates timely dissemination of research findings, supporting innovation and collaboration across academia, industry, and clinical practice. It is an essential resource for professionals seeking to advance drug formulation, delivery technologies, and therapeutic outcomes in modern medicine.

Current Drug Delivery (CDD) is :-

• International, Peer-Reviewed, Open Access, Refereed, Novel drug and vaccine delivery technologies, Nanocarrier systems (liposomes, nanoparticles, micelles, Physico‑chemical and biological delivery methods, Transport mechanisms including efflux proteins & multidrug resistance, Delivery of small molecules, peptides, proteins, nucleotides, sugars, Pharmaceutical Science , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1567-2018, E-ISSN: 1875-5704, Established: 2004, Impact Factor: 3.0
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE